JOHNSON INVESTMENT COUNSEL INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
JOHNSON INVESTMENT COUNSEL INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$162,064
-5.9%
10,476
-4.4%
0.00%0.0%
Q2 2023$172,197
-5.3%
10,961
-0.6%
0.00%0.0%
Q1 2023$181,741
+3.3%
11,028
-2.2%
0.00%0.0%
Q4 2022$175,952
+18.9%
11,279
-0.9%
0.00%0.0%
Q3 2022$148,000
-6.3%
11,380
+0.9%
0.00%0.0%
Q2 2022$158,000
+7.5%
11,279
+9.8%
0.00%0.0%
Q1 2022$147,000
+1.4%
10,273
-3.7%
0.00%0.0%
Q4 2021$145,000
-39.3%
10,673
-26.9%
0.00%
-33.3%
Q3 2021$239,000
-10.2%
14,600
-5.3%
0.00%
-25.0%
Q2 2021$266,000
-7.6%
15,419
-2.4%
0.00%0.0%
Q1 2021$288,000
-3.0%
15,797
-3.2%
0.00%
-20.0%
Q4 2020$297,000
+1.7%
16,314
-0.5%
0.01%0.0%
Q3 2020$292,000
-3.9%
16,389
-1.2%
0.01%
-16.7%
Q2 2020$304,000
+21.1%
16,585
+0.5%
0.01%0.0%
Q1 2020$251,000
-23.0%
16,5050.0%0.01%0.0%
Q4 2019$326,000
+16.4%
16,505
+1.2%
0.01%0.0%
Q3 2019$280,00016,3050.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders